Differential diagnosis of parotid gland tumours: which magnetic resonance findings should be taken in account?
- PMID: 26824912
- PMCID: PMC4720931
- DOI: 10.14639/0392-100X-693
Differential diagnosis of parotid gland tumours: which magnetic resonance findings should be taken in account?
Abstract
Our aim was to define typical magnetic resonance (MRI) findings in malignant and benign parotid tumours. This study is based on retrospective evaluation of pre-surgical MRI of 94 patients with parotid gland tumours. Histology results were available for all tumours. There were 69 cases of benign (73%) and 25 cases of malignant (27%) tumours, including 44 pleomorphic adenomas, 18 Warthin's tumours, 7 various benign tumours, 6 squamous cell carcinomas, 3 carcinoma ex pleomorphic adenomas, 2 mucoepidermoid carcinomas, 1 adenoid cystic carcinoma and 13 various malignant tumours. The following MRI parameters were evaluated: shape, site, size, margins, signal intensity (SI) on T1w and T2w images, contrast enhancement, signal of cystic content, presence or absence of a capsule, perineural spread, extraglandular growth pattern and cervical adenopathy. Statistical analysis was performed to identify the MRI findings most suggestive of malignancy, and to define the most typical MRI pattern of the most common histologies. Ill-defined margins (p < 0.001), adenopathies (p < 0.001) and infiltrative grown pattern (p < 0.001) were significantly predictive of malignancy. Typical findings of pleomorphic adenoma included hyperintensity on T2w images (p = 0.02), strong contrast enhancement (p < 0.001) and lobulated shape (p = 0.04). Typical findings of Warthin's tumour included hyperintense components on T1w images (p < 0.001), location in the parotid inferior process (p < 0.001) and mild or incomplete contrast enhancement (p = 0.01). SI on T1w and T2w images and contrast enhancement enables differential diagnosis between pleomorphic adenoma and Warthin's tumour.
La finalità del nostro lavoro è di valutare le caratteristiche di risonanza magnetica (RM) tipiche dei tumori parotidei maligni e benigni. Questo studio retrospettivo si basa sulla valutazione di esami RM pre-chirurgici di 94 pazienti con tumori parotidei. I risultati istologici erano disponibili in tutti i casi; abbiamo analizzato 69 lesioni erano benigne (73%) e 25 maligne (27%): 44 adenomi pleomorfi, 18 tumori di Warthin, 7 tumori benigni di diverso istotipo, 6 carcinomi squamocellulari, 3 carcinomi ex-adenomi pleomorfi, 2 carcinomi mucoepidermoidi, 1 tumore adenoidocistico, 13 tumori maligni di diverso istotipo. Sono state valutate le seguenti caratteristiche RM: morfologia, sede, dimensioni, margini, intensità di segnale nelle sequenze T2-pesate e T1-pesate, impregnazione dopo mezzo di contrasto (mdc), intensità di segnale della porzione cistica, presenza o assenza di una capsula, diffusione perineurale, pattern di crescita extraghiandolare e linfoadenopatie laterocervicali. È stata effettuata un'analisi statistica per identificare le caratteristiche RM più indicative di malignità e per definire l'aspetto tipico degli istotipi più comuni. I parametri significativamente predittivi di malignità sono risultati i margini mal-definiti (p < 0,001), le linfoadenopatie (p < 0,001) ed il pattern di crescita infiltrativo (p < 0,001). Le caratteristiche tipiche dell'adenoma pleomorfo sono risultate l'iperintensità di segnale nelle immagini T2-pesate (p = 0,02), l'intensa impregnazione dopo mdc (p < 0,001) ed i margini lobulati (p = 0,04). Le caratteristiche tipiche del tumore di Warthin sono risultate le componenti iperintense nelle immagini T1-pesate (p < 0,001), la localizzazione nel processo parotideo inferiore (p < 0,001) e l'impregnazione post-contrastografica lieve/incompleta (p = 0,01). L'intensità di segnale nelle immagini T1-pesate e T2- pesate e l'impregnazione post-contrastografica si sono rivelate utili nella diagnosi differenziale tra adenoma pleomorfo e tumore di Warthin.
Keywords: Differential diagnosis; Histology; Magnetic Resonance Imaging; Neoplasms; Parotid gland.
Figures




Similar articles
-
Usefulness of heavily T(2) weighted magnetic resonance images for the differential diagnosis of parotid tumours.Dentomaxillofac Radiol. 2003 Sep;32(5):295-9. doi: 10.1259/dmfr/32387150. Dentomaxillofac Radiol. 2003. PMID: 14709603
-
Perfusion imaging of parotid gland tumours: usefulness of arterial spin labeling for differentiating Warthin's tumours.Eur Radiol. 2015 Nov;25(11):3247-54. doi: 10.1007/s00330-015-3755-7. Epub 2015 Apr 29. Eur Radiol. 2015. PMID: 25921591
-
Capsule of parotid gland tumor: evaluation by 3.0 T magnetic resonance imaging using surface coils.Acta Radiol. 2010 Dec;51(10):1103-10. doi: 10.3109/02841851.2010.519716. Epub 2010 Oct 1. Acta Radiol. 2010. PMID: 20883183
-
Multiparametric magnetic resonance imaging of parotid tumors: A systematic review.Diagn Interv Imaging. 2021 Mar;102(3):121-130. doi: 10.1016/j.diii.2020.08.002. Epub 2020 Sep 14. Diagn Interv Imaging. 2021. PMID: 32943368
-
The role of imaging in the evaluation of parotid disease.Clin Radiol. 2002 Aug;57(8):692-701. doi: 10.1053/crad.2001.0865. Clin Radiol. 2002. PMID: 12169280 Review.
Cited by
-
Using Machine Learning on MRI Radiomics to Diagnose Parotid Tumours Before Comparing Performance with Radiologists: A Pilot Study.J Imaging Inform Med. 2025 Jun;38(3):1496-1508. doi: 10.1007/s10278-024-01255-y. Epub 2024 Oct 10. J Imaging Inform Med. 2025. PMID: 39390287 Free PMC article.
-
The Role of Radiomics in Salivary Gland Imaging: A Systematic Review and Radiomics Quality Assessment.Diagnostics (Basel). 2022 Dec 1;12(12):3002. doi: 10.3390/diagnostics12123002. Diagnostics (Basel). 2022. PMID: 36553009 Free PMC article. Review.
-
Can Magnetic Resonance Radiomics Analysis Discriminate Parotid Gland Tumors? A Pilot Study.Diagnostics (Basel). 2020 Nov 3;10(11):900. doi: 10.3390/diagnostics10110900. Diagnostics (Basel). 2020. PMID: 33153140 Free PMC article.
-
The Role of MRI Radiomics Using T2-Weighted Images and the Apparent Diffusion Coefficient Map for Discriminating Between Warthin's Tumors and Malignant Parotid Gland Tumors.Cancers (Basel). 2025 Feb 12;17(4):620. doi: 10.3390/cancers17040620. Cancers (Basel). 2025. PMID: 40002215 Free PMC article.
-
An Overview on the Histogenesis and Morphogenesis of Salivary Gland Neoplasms and Evolving Diagnostic Approaches.Cancers (Basel). 2021 Aug 3;13(15):3910. doi: 10.3390/cancers13153910. Cancers (Basel). 2021. PMID: 34359811 Free PMC article. Review.
References
-
- Tian Z, Li L, Wang L, et al. Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population. Int J Oral Maxillofac Surg. 2010;39:235–242. - PubMed
-
- Nagler RM, Laufer D. Tumors of the major and minor salivary glands: review of 25 years of experience. Anticancer Res. 1997;17:701–707. - PubMed
-
- Eveson JW, Cawson RA. Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 1985;146:51–58. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical